Peder Jensen - Net Worth and Insider Trading
Peder Jensen Net Worth
The estimated net worth of Peder Jensen is at least $486,600 dollars as of 2024-09-21. Peder Jensen is the Director of BioCryst Pharmaceuticals Inc and owns about 60,000 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $486,600. Peder Jensen is also the Director of Five Prime Therapeutics Inc and owns about 0 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $0. Details can be seen in Peder Jensen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peder Jensen has not made any transactions after 2016-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peder Jensen
Peder Jensen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peder Jensen owns 3 companies in total, including Acorda Therapeutics Inc (ACORQ) , Five Prime Therapeutics Inc (FPRX) , and BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Peder Jensen’s form 4 insider trades.
Insider Ownership Summary of Peder Jensen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACORQ | Acorda Therapeutics Inc | 2011-04-19 | director |
| FPRX | Five Prime Therapeutics Inc | 2020-05-14 | director |
| BCRX | BioCryst Pharmaceuticals Inc | 2012-12-14 | director |
Peder Jensen Latest Holdings Summary
Peder Jensen currently owns a total of 2 stocks. Among these stocks, Peder Jensen owns 60,000 shares of BioCryst Pharmaceuticals Inc (BCRX) as of December 14, 2012, with a value of $486,600 and a weighting of 100%. Peder Jensen also owns 0 shares of Five Prime Therapeutics Inc (FPRX) as of November 9, 2016, with a value of $0 and a weighting of 0%.
Latest Holdings of Peder Jensen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2012-12-14 | 60,000 | 8.11 | 486,600 |
| FPRX | Five Prime Therapeutics Inc | 2016-11-09 | 0 | 38.00 | 0 |
Holding Weightings of Peder Jensen
Peder Jensen Form 4 Trading Tracker
According to the SEC Form 4 filings, Peder Jensen has made a total of 0 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 20,000 shares on December 14, 2012, which cost Peder Jensen around $30,200.
According to the SEC Form 4 filings, Peder Jensen has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the sale of 8,130 shares on November 9, 2016, which brought Peder Jensen around $449,589.
Insider Trading History of Peder Jensen
- 1
Peder Jensen Trading Performance
GuruFocus tracks the stock performance after each of Peder Jensen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peder Jensen is 15.15%. GuruFocus also compares Peder Jensen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peder Jensen within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peder Jensen's insider trading performs compared to the benchmark.
Performance of Peder Jensen
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.03 | | | | | |
| Relative Return to S&P 500(%) | 8.78 | | | | | |
Peder Jensen Ownership Network
Peder Jensen Owned Company Details
What does Acorda Therapeutics Inc do?
Who are the key executives at Acorda Therapeutics Inc?
Peder Jensen is the director of Acorda Therapeutics Inc. Other key executives at Acorda Therapeutics Inc include CEO and President Ron Cohen , Chief Financial Officer Michael A Gesser , and General Counsel Neil S. Belloff .
Acorda Therapeutics Inc (ACORQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Acorda Therapeutics Inc (ACORQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Acorda Therapeutics Inc (ACORQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Acorda Therapeutics Inc (ACORQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acorda Therapeutics Inc Insider Transactions
Peder Jensen Mailing Address
Above is the net worth, insider trading, and ownership report for Peder Jensen. You might contact Peder Jensen via mailing address: C/o Acorda Therapeutics, Inc., 420 Saw Mill River Road, Ardsley Ny 10502.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
